the development of doca/salt hypertension , as monitored by tail-cuff plethysmography , was prevented by : ( a ) destruction of the peripheral adrenergic nerves with neonatal administration of guanethidine ( 80 mg/kg subcutaneously for the first 14 days postnatally ) ;
C0020538
hypertension
C0018318
guanethidine